Hyperparathyroidism, Secondary: all 190 studies

Page 2 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).CompletedNCT04750460Phase 3
• Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet TreatmentCompletedNCT04637360Not applicable
• Preemptive and Precise Intervention for CKD-SHPTStatus unknownNCT04523974
• IOPTH Usefulness for Predicting Successful Surgery in Secondary HyperparathyroidismCompletedNCT04484116
• Pulmonary Function, Voice and Swallowing Symptoms After ParathyroidectomyCompletedNCT04267965
• Study on the Use of Cinacalcet in Phosphocalcic Context.Status unknownNCT04126954
• Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent PatientsCompletedNCT03937349
• Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedNCT03822507Phase 3
• Phase 3 Study of SK-1403CompletedNCT03801980Phase 3
• Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis PatientsCompletedNCT03724188
• Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy SubjectsCompletedNCT03660800Phase 1
• SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving HemodialysisCompletedNCT03626948Phase 3
• Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney DiseaseCompletedNCT03626246
• The Longitudinal PTH-StudyCompletedNCT03464149
• Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT03226171Phase 2
• the Study on Prognostic for Hemodialysis PatientsStatus unknownNCT03194087
• Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis PatientsCompletedNCT03182699Phase 4
• Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic NephropathyCompletedNCT03137316
• Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedNCT03123406Phase 4
• The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease PatientsStatus unknownNCT03082742Not applicable
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney DiseaseWithdrawnNCT03063190Phase 4
• Intravenous Paricalcitol in Chronic Hemodialysis PatientsStatus unknownNCT03023748Phase 4
• Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.CompletedNCT02895061Not applicable
• Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric BypassCompletedNCT02830789Not applicable
• Phase 3 Study of KHK7580CompletedNCT02549417Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549404Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549391Phase 2/3
• Comparison of Total Parathyroidectomy With and Without AutotransplantationStatus unknownNCT02536287Phase 3
• Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary HyperparathyroidismCompletedNCT02524041Not applicable
• Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal TransplantationCompletedNCT02523209
• Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under DialysisActive, not recruitingNCT02464072Not applicable
• Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis PatientsStatus unknownNCT02338934Phase 4
• The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing HemodialysisStatus unknownNCT02332135Not applicable
• Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidCompletedNCT02274623Phase 1
• Optimal Anemia Treatment in End Stage Renal Disease (ERSD)Status unknownNCT02273570Not applicable
• Phase 2 Study of KHK7580CompletedNCT02216656Phase 2
• Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal DialysisCompletedNCT02143271Phase 1
• A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing HemodialysisCompletedNCT02133404Phase 2
• The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of ParathyroidCompletedNCT02056730Phase 4
• Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving HemodialysisCompletedNCT01935856Phase 1/2
• A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on HemodialysisCompletedNCT01922843Phase 2
• Morbidity Related to Secondary Hyperparathyroidism After Renal TransplantationCompletedNCT01741064
• A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary HyperparathyroidismCompletedNCT01653379Phase 2
• Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)Status unknownNCT01479088Phase 2/3
• Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)WithdrawnNCT01453634Phase 2
• Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis PatientsCompletedNCT01447368Phase 4
• Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney DiseaseWithdrawnNCT01426724Not applicable
• Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary HyperparathyroidismWithdrawnNCT01421407Not applicable
• Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary HyperparathyroidismCompletedNCT01220050Phase 2
• Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal TransplantationCompletedNCT01178450Phase 4
• LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism PatientsCompletedNCT01167309Phase 1
• A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
• Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary HyperparathyroidismCompletedNCT01115543Phase 4
• Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH LevelCompletedNCT01101113Phase 4
• Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral DensityCompletedNCT01025128Phase 4
• Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney DiseaseCompletedNCT00995163
• Vitamin D Deficiency in Chronic Kidney Disease (CKD) PatientsCompletedNCT00958451Phase 4
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease SubjectsCompletedNCT00888069Phase 1
• Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary HyperparathyroidismCompletedNCT00800358Not applicable
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)CompletedNCT00792857Phase 1
• Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney DiseaseCompletedNCT00781417Not applicable
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney DiseaseCompletedNCT00742716Phase 2
• Bioequivalency Study of Calcitriol Tablets Under Fasting ConditionsCompletedNCT00601328Not applicable
• Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
• Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599Not applicable
• A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCompletedNCT00463021Phase 4
• A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCompletedNCT00454350Phase 4
• Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisTerminatedNCT00446329Phase 4
• A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on DialysisCompletedNCT00418600Phase 4
• Evaluation of Colecalciferol Substitution in Dialysis PatientsCompletedNCT00397475Not applicable
• Post Transplant StudyCompletedNCT00395902
• Calcium and Vitamin D Malnutrition in Elderly WomenCompletedNCT00352170Phase 3
• Initial Dosing of Paricalcitol in Secondary HyperparathyroidismCompletedNCT00307840Phase 4
• Characterization of Hyperparathyroidism and Vitamin D Deficiency in ObesityCompletedNCT00288873Phase 4
• CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis PatientsCompletedNCT00211939Phase 4
• A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)CompletedNCT00189501
• Active Vitamin D Effect on Left Ventricular HypertrophyTerminatedNCT00175149Phase 4
• ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismCompletedNCT00135304Phase 4
• START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary HyperparathyroidismCompletedNCT00132431Phase 4
• Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCompletedNCT00123461Phase 4
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCompletedNCT00117052Phase 3
• Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)CompletedNCT00113945Phase 2
• Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)CompletedNCT00110929Phase 2
• Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving DialysisCompletedNCT00094484Phase 3
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of CalciumCompletedNCT00073710Phase 4
• Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on HemodialysisCompletedNCT00053547Phase 4
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCompletedNCT00042653Phase 3
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis PatientsCompletedNCT00037635Phase 3
• Acute Regulation of Parathyroid Hormone by Dietary PhosphateCompletedNCT00037193

← Hyperparathyroidism, Secondary overview